Dr. Shane Richard Stecklein, MD, PhD

Dr. Stecklein practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Stecklein's NPI, 1730506932, was assigned on March 25, 2014. Dr. Stecklein graduated from University of Kansas School of Med (KC/Wich/Sal) in 2014. Dr. Stecklein holds Kansas license 04-41941.

Dr. Stecklein's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Stecklein's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Stecklein is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Stecklein to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stecklein practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Stecklein's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Stecklein's licenses on file in 2 states: Kansas and Missouri.

CMS data shows 1,109 Medicare services from Dr. Stecklein across 18 procedure codes in 2024, for 222 Medicare patients. Medicare paid $67,307 for them.

CMS counts 222 Medicare patients who saw Dr. Stecklein in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high cholesterol, and 72% have cancer. 5% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stecklein's median patient age at 72, with 73% women.

In 2024, Dr. Stecklein wrote 81 Medicare Part D claims for 33 patients. 96% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $882 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

Dr. Stecklein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 37 papers to Dr. Stecklein, published from 2012 to 2024. 2018 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Triple Negative Breast Neoplasms and Antibodies, Monoclonal, Humanized. Dr. Stecklein has published most often in Ann Oncol. Dr. Stecklein's most frequent co-authors are Wendy A. Woodward, MD, PhD, Anne P. O'Dea, MD and Simona F. Shaitelman, MD.

Dmand AI links Dr. Stecklein to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 7 general payments to Dr. Stecklein from 6 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 85% of the total. Novocure Inc. paid the most, $118.

Dr. Stecklein graduated from University of Kansas School of Med (KC/Wich/Sal) in 2014.